These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

98 related articles for article (PubMed ID: 11183353)

  • 21. [Renal failure after eczema treatment with Chinese herbal medicine].
    Hautarzt; 2000 Apr; 51(4):297. PubMed ID: 10810668
    [No Abstract]   [Full Text] [Related]  

  • 22. On a nephrotoxic and carcinogenic slimming regimen.
    De Broe ME
    Am J Kidney Dis; 1999 Jun; 33(6):1171-3. PubMed ID: 10352210
    [No Abstract]   [Full Text] [Related]  

  • 23. Re: Population-based case-control study of Chinese herbal products containing aristolochic acid and urinary tract cancer risk.
    Su YC; Lin JS; Lee MT; Li TC; Lee SM
    J Natl Cancer Inst; 2010 Jul; 102(13):988; author reply 988-90. PubMed ID: 20479292
    [No Abstract]   [Full Text] [Related]  

  • 24. New perspectives on the Chinese herbal nephropathy.
    Jia W; Zhao A; Gao W; Chen M; Xiao P
    Phytother Res; 2005 Nov; 19(11):1001-2. PubMed ID: 16317661
    [No Abstract]   [Full Text] [Related]  

  • 25. Aristolochic acid as a causative factor in a case of Chinese herbal nephropathy.
    Cronin AJ; Maidment G; Cook T; Kite GC; Simmonds MS; Pusey CD; Lord GM
    Nephrol Dial Transplant; 2002 Mar; 17(3):524-5. PubMed ID: 11865112
    [No Abstract]   [Full Text] [Related]  

  • 26. Alternative medicine. Herbal product linked to cancer.
    Greensfelder L
    Science; 2000 Jun; 288(5473):1946. PubMed ID: 10877707
    [No Abstract]   [Full Text] [Related]  

  • 27. Aristolochic acid mutational signature defines the low-risk subtype in upper tract urothelial carcinoma.
    Lu H; Liang Y; Guan B; Shi Y; Gong Y; Li J; Kong W; Liu J; Fang D; Liu L; He Q; Shakeel M; Li X; Zhou L; Ci W
    Theranostics; 2020; 10(10):4323-4333. PubMed ID: 32292497
    [No Abstract]   [Full Text] [Related]  

  • 28. Urothelial lesions in Chinese-herb nephropathy.
    Cosyns JP; Jadoul M; Squifflet JP; Wese FX; van Ypersele de Strihou C
    Am J Kidney Dis; 1999 Jun; 33(6):1011-7. PubMed ID: 10352187
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Traditional remedy-induced Chinese herbs nephropathy showing rapid deterioration of renal function].
    Tanaka A; Nishida R; Sawai K; Nagae T; Shinkai S; Ishikawa M; Maeda K; Murata M; Seta K; Okuda J; Yoshida T; Sugawara A; Kuwahara T
    Nihon Jinzo Gakkai Shi; 1997 Dec; 39(8):794-7. PubMed ID: 9483946
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Reversible Fanconi syndrome after ingestion of a Chinese herbal 'remedy' containing aristolochic acid.
    Krumme B; Endmeir R; Vanhaelen M; Walb D
    Nephrol Dial Transplant; 2001 Feb; 16(2):400-2. PubMed ID: 11158421
    [No Abstract]   [Full Text] [Related]  

  • 31. Urothelial malignancy in nephropathy due to Chinese herbs.
    Cosyns JP; Jadoul M; Squifflet JP; Van Cangh PJ; van Ypersele de Strihou C
    Lancet; 1994 Jul; 344(8916):188. PubMed ID: 7912776
    [No Abstract]   [Full Text] [Related]  

  • 32. Chinese herbs containing aristolochic acid associated with renal failure and urothelial carcinoma: a review from epidemiologic observations to causal inference.
    Yang HY; Chen PC; Wang JD
    Biomed Res Int; 2014; 2014():569325. PubMed ID: 25431765
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Population-based case-control study of Chinese herbal products containing aristolochic acid and urinary tract cancer risk.
    Lai MN; Wang SM; Chen PC; Chen YY; Wang JD
    J Natl Cancer Inst; 2010 Feb; 102(3):179-86. PubMed ID: 20026811
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Detection of DNA adducts formed by aristolochic acid in renal tissue from patients with Chinese herbs nephropathy.
    Schmeiser HH; Bieler CA; Wiessler M; van Ypersele de Strihou C; Cosyns JP
    Cancer Res; 1996 May; 56(9):2025-8. PubMed ID: 8616845
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Aristolochic acid nephropathy in a Chinese patient: time to abandon the term "Chinese herbs nephropathy"?
    Gillerot G; Jadoul M; Arlt VM; van Ypersele De Strihou C; Schmeiser HH; But PP; Bieler CA; Cosyns JP
    Am J Kidney Dis; 2001 Nov; 38(5):E26. PubMed ID: 11684578
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Chinese herbal nephropathy and urothelial malignancy.
    Mason RG; Donaldson D
    J R Soc Promot Health; 2002 Dec; 122(4):266-7. PubMed ID: 12557737
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Chinese herb nephropathy in Japan presents adult-onset Fanconi syndrome: could different components of aristolochic acids cause a different type of Chinese herb nephropathy?
    Tanaka A; Nishida R; Maeda K; Sugawara A; Kuwahara T
    Clin Nephrol; 2000 Apr; 53(4):301-6. PubMed ID: 10809420
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Increased risk of urinary tract cancer in ESRD patients associated with usage of Chinese herbal products suspected of containing aristolochic acid.
    Wang SM; Lai MN; Wei A; Chen YY; Pu YS; Chen PC; Wang JD
    PLoS One; 2014; 9(8):e105218. PubMed ID: 25170766
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Identification of aristolochic acid in Chinese herbs.
    Vanhaelen M; Vanhaelen-Fastre R; But P; Vanherweghem JL
    Lancet; 1994 Jan; 343(8890):174. PubMed ID: 7904018
    [No Abstract]   [Full Text] [Related]  

  • 40. Aristolochic acid and its effect on different cancers in uro-oncology.
    Rebhan K; Ertl IE; Shariat SF; Grollman AP; Rosenquist T
    Curr Opin Urol; 2020 Sep; 30(5):689-695. PubMed ID: 32701724
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.